SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Johnston, A. L.
Right arrow Articles by File, S. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Johnston, A. L.
Right arrow Articles by File, S. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Measures of anxiety and stress in the rat following chronic treatment with yohimbine

Amanda L. Johnston

MRC Neuropharmacology Research Group, Department of Pharmacology, The School of Pharmacy, University of London, 29-39 Brunswick Square, London WC1N 1AX

Helen A. Baldwin

MRC Neuropharmacology Research Group, Department of Pharmacology, The School of Pharmacy, University of London, 29-39 Brunswick Square, London WC1N 1AX

Sandra E. File

MRC Neuropharmacology Research Group, Department of Pharmacology, The School of Pharmacy, University of London, 29-39 Brunswick Square, London WC1N 1AX

Yohimbine (2.5 and 5 mg/kg) was investigated in two animal tests of anxiety and on baseline corticosterone plasma concentrations, following both acute and chronic administration. Acute treatment with yohimbine produced the following effects: a reduction in the percentage of total arm entries made onto the open arms and in the percentage of time spent on the open arms of an elevated plus-maze (indicating anxiogenic properties), an increase in baseline plasma corticosterone concentrations, and a reduction in locomotor activity (recorded in the social interaction test). No significant effects were observed on anxiety levels as measured by the social interaction test. Following chronic treatment, we saw no evidence for sensitization to the effects of yohimbine.

Journal of Psychopharmacology, Vol. 2, No. 1, 33-38 (1988)
DOI: 10.1177/026988118800200106


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J PsychopharmacolHome page
S. K. Bhattacharya, P. J. R. Mohan Rao, and A. P. Sen
Anxiogenic activity of intraventricularly administered bradykinin in rats
J Psychopharmacol, January 1, 1995; 9(4): 348 - 354.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
S. K. Bhattacharya, S. K. Mitra, and S. B. Acharya
Anxiogenic activity of isatin, a putative biological factor, in rodents
J Psychopharmacol, January 1, 1991; 5(3): 202 - 206.
[Abstract] [PDF]



Advertisement